SCI时时刷

search
+
The Role of Radiotherapy in the Contemporary Management of Patients With Sarcoma: Opportunities to Improve Patient Outcomes
The Role of Radiotherapy in the Contemporary Management of Patients With Sarcoma: Opportunities to Improve Patient Outcomes
J-Y Blay et al.Surgery in reference centers improves survival of sarcoma patients: A nationwide studyAnn Oncol(2019)A Borg...
Extremity and Truncal Soft Tissue Sarcoma: Risk Assessment and Multidisciplinary Management
Extremity and Truncal Soft Tissue Sarcoma: Risk Assessment and Multidisciplinary Management
Soft tissue sarcomas (STS) are a heterogeneous group of malignant tumors with over 150 different histological and molecula...
Progress in Retroperitoneal Sarcoma Management: Surgical and Radiotherapy Approaches
Progress in Retroperitoneal Sarcoma Management: Surgical and Radiotherapy Approaches
Volume 34, Issue 2, April 2024, Pages 164-171Author links open overlay panel, , , Surgical resection is the cornerstone of...
Unraveling the Myth of Radiation Resistance in Soft Tissue Sarcomas
Unraveling the Myth of Radiation Resistance in Soft Tissue Sarcomas
Volume 34, Issue 2, April 2024, Pages 172-179Author links open overlay panel, , , There is a misconception that sarcomas a...
Are We Ready for Life in the Fast Lane? A Critical Review of Preoperative Hypofractionated Radiotherapy for Localized Soft Tissue Sarcoma
Are We Ready for Life in the Fast Lane? A Critical Review of Preoperative Hypofractionated Radiotherapy for Localized Soft Tissue Sarcoma
Soft tissue sarcomas (STS) are rare, constituting < 1% of adult cancers.1 This category of malignancies consists of mor...
Opportunity in Complexity: Harnessing Molecular Biomarkers and Liquid Biopsies for Personalized Sarcoma Care
Opportunity in Complexity: Harnessing Molecular Biomarkers and Liquid Biopsies for Personalized Sarcoma Care
Sarcomas are a rare and heterogeneous group of malignancies that affect patients of all ages and arise from mesenchymal ce...
The Use of Proton and Carbon Ion Radiation Therapy for Sarcomas
The Use of Proton and Carbon Ion Radiation Therapy for Sarcomas
Particle therapy first emerged in 1946 under physicist Dr. Robert Wilson who recognized the potential therapeutic advantag...
FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the Treatment of Patients With Sarcoma?
FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the Treatment of Patients With Sarcoma?
For patients with sarcoma, radiotherapy (RT) plays an important role in both definitive and palliative disease management....
Immunotherapy and Radiotherapy Combinations for Sarcoma
Immunotherapy and Radiotherapy Combinations for Sarcoma
Sarcomas are cancers derived from mesenchymal tissue and account for approximately 1% of adult malignancies, based on the ...
Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas
Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas
Over the past decade, immunotherapy has become a cornerstone in treating various malignancies. Chimeric antigen receptor (...
Magnetic Resonance Imaging Guided Radiation Therapy: Overview
Magnetic Resonance Imaging Guided Radiation Therapy: Overview
D Low et al.MRI-Guided Radiation Therapy SystemsSemin Radiat Ther(2023)P Courtney et al.MRI-guided radiation therapy—An em...
MRI-Guided Radiation Therapy—An Emerging and Disruptive Process of Care: Healthcare Economic and Policy Considerations
MRI-Guided Radiation Therapy—An Emerging and Disruptive Process of Care: Healthcare Economic and Policy Considerations
Radiation oncology is a field constantly seeking to improve patient outcomes by bringing novel and sophisticated treatment...
MRI-Guided Radiation Therapy Systems
MRI-Guided Radiation Therapy Systems
Volume 34, Issue 1, January 2024, Pages 14-22Author links open overlay panel, , MR-Guided Radiation Therapy (MRIgRT) has b...
The Use of MR-Guided Radiation Therapy for Pancreatic Cancer
The Use of MR-Guided Radiation Therapy for Pancreatic Cancer
Pancreatic cancer (pancreatic ductal adenocarcinoma; PDAC) remains a lethal malignancy with a 5-year survival rate of only...
The Use of MR-Guided Radiation Therapy for Liver Cancer
The Use of MR-Guided Radiation Therapy for Liver Cancer
Volume 34, Issue 1, January 2024, Pages 36-44Author links open overlay panel, , , , , The role of radiotherapy in the mana...
MRI-Guided Radiotherapy for Prostate Cancer: Seeing is Believing
MRI-Guided Radiotherapy for Prostate Cancer: Seeing is Believing
Prostate cancer is the most common non-cutaneous malignancy affecting men, with an estimated 268,490 cases diagnosed in th...
Exploring the Advantages and Challenges of MR-Guided Radiotherapy in Non–Small-Cell Lung Cancer: Who are the Optimal Candidates?
Exploring the Advantages and Challenges of MR-Guided Radiotherapy in Non–Small-Cell Lung Cancer: Who are the Optimal Candidates?
Lung cancer is a significant burden on the population and health care system as the second most commonly diagnosed cancer,...
Rectal Cancer MRI Guided Radiotherapy: A Practical Review for the Physician
Rectal Cancer MRI Guided Radiotherapy: A Practical Review for the Physician
Magnetic resonance imaging (MRI) is considered the gold standard for the investigation and assessment of locally advanced ...
The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance
The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance
Volume 34, Issue 1, January 2024, Pages 69-83Author links open overlay panel, , , Although magnetic resonance imaging (MRI...
MRI-Guided Adaptive Radiation Therapy
MRI-Guided Adaptive Radiation Therapy
Approximately half of patients diagnosed with cancer will be treated with radiation therapy (RT)1 Treatment efficacy depen...
Intrafraction Motion Management With MR-Guided Radiation Therapy
Intrafraction Motion Management With MR-Guided Radiation Therapy
In radiation oncology, continuous physiological changes cause the patients anatomy during treatment to deviate from the on...
Quantitative MRI on MR-Linacs: Towards Biological Image-Guided Adaptive Radiotherapy
Quantitative MRI on MR-Linacs: Towards Biological Image-Guided Adaptive Radiotherapy
The potential of functional imaging methods in radiation oncology was identified over 2 decades ago when Ling et al.1 prop...
The Quality Assurance of a 1.5 T MR-Linac
The Quality Assurance of a 1.5 T MR-Linac
Volume 34, Issue 1, January 2024, Pages 120-128Author links open overlay panel, , , The recent introduction of a commercia...
MRgRT Quality Assurance for a Low-Field MR-Linac
MRgRT Quality Assurance for a Low-Field MR-Linac
Volume 34, Issue 1, January 2024, Pages 129-134Author links open overlay panelThe introduction of MR-guided treatment mach...
The Future of MR-Guided Radiation Therapy
The Future of MR-Guided Radiation Therapy
Volume 34, Issue 1, January 2024, Pages 135-144Author links open overlay panel, , , , , Magnetic resonance image guided ra...
Optimizing Informed Consent in Cancer Clinical Trials
Optimizing Informed Consent in Cancer Clinical Trials
Volume 33, Issue 4, October 2023, Pages 349-357Author links open overlay panel, , The concept of informed consent has evol...
Patient-Reported Outcomes in Clinical Trials: From an Endpoint to an Intervention in Cancer Care
Patient-Reported Outcomes in Clinical Trials: From an Endpoint to an Intervention in Cancer Care
A patient-reported outcome (PRO) tool is “a measurement of any aspect of a patient's health status that comes directly fro...
Selection and Prejudice: Addressing Clinical Trial Disparities With a Review of Current Shortcomings and Future Directions
Selection and Prejudice: Addressing Clinical Trial Disparities With a Review of Current Shortcomings and Future Directions
Randomized clinical trials (RCTs) are often considered the highest level of evidence to guide medical practice. Unlike oth...
Real-World Data: Applications and Relevance to Cancer Clinical Trials
Real-World Data: Applications and Relevance to Cancer Clinical Trials
In medicine, randomized controlled trials (RCTs) are considered the gold standard for evaluating the efficacy and safety o...
Integrating Artificial Intelligence and Machine Learning Into Cancer Clinical Trials
Integrating Artificial Intelligence and Machine Learning Into Cancer Clinical Trials
In just a few years, we have seen artificial intelligence (AI) and machine learning (ML) in healthcare transition from buz...
阅读更多
format_indent_increase